Medtronic Pipeline Vantage device recall: deformation may cause blood clots
The Pipeline Vantage Embolization Device may malfunction, with the braid deforming or not positioning correctly, potentially causing blood clots. Approximately 7,820 units are affected worldwide.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification establishes a minimum severity of 4. The source describes device malfunction (incomplete wall apposition and braid deformation) that can lead to thrombosis and serious adverse events, but no actual illnesses or injuries have been reported.
Plain-English summary
The Medtronic Pipeline Vantage Embolization Device with Shield Technology is the subject of a Class I recall by manufacturer Micro Therapeutics, Inc., affecting approximately 7,820 units.
The device may fail to position correctly against the vessel wall (incomplete wall apposition) or may experience braid deformation, such as narrowing or collapse. These failures typically occur during or shortly after the procedure but are often detected during follow-up imaging performed 6 to 12 months post-procedure. The malfunction can potentially lead to blood clots and other serious adverse events.
The affected devices have been distributed worldwide to healthcare facilities in the United States, U.S. territories, and many countries internationally. Female patients 45 years of age and younger are identified as being at higher risk.
The recalled product
- Product
- Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PED3-021-275-12, PED3-021-275-16, PED3-021-325-12, PED3-021-325-14, PED3-021-325-16, PED3-021-325-20…
- Manufacturer
- Micro Therapeutics, Inc.
- Affected units
- 7,820
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Instructions for Use
- Version: Rev. A (01/2024). REF/UDI-DI/Lot: PED3-021-350-16/00847536030701
- 00847536035195
- 00847536036529/B317460
- B327449
- B335184
- B340948
- B349032
- B389162
- B392918
- B424454
- B430015
- B495821
- B497938
- B547396
- B550307
- B551615
- B559033
- B603377
- B623564
Distribution
Part of a larger recall action
This product is one of 2 recalled by Micro Therapeutics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Micro Therapeutics, Inc.
See all →- ModerateMicro Therapeutics Recalls Pipeline Flex Embolization Device Due to Labeling Error
FDA (Devices) · 2026-10-07
- ModeratePipeline Flex Embolization Devices Recalled Due to Incorrect Labeling of Implant Length
FDA (Devices) · 2026-07-29
- ModerateEmbolization devices recalled due to incorrect labeling of implant dimensions
FDA (Devices) · 2026-07-29
- SevereMedtronic Pipeline Vantage Embolization Device Recall for Structural Deformation Risk
FDA (Devices) · 2025-03-12
- HighApollo Onyx Delivery Microcatheter recalled for incorrect indications for use
FDA (Devices) · 2024-03-13
Similar recalls
- SevereEv3 Pipeline Flex Embolization Device Recalled for Delivery System Fracture Risk
FDA (Devices) · 2020-04-01
- SevereEV3 Pipeline Flex Embolization Device Recalled for Push Wire Fracture Risk
FDA (Devices) · 2021-09-15
- Severeev3 Pipeline Flex Embolization Device Recalled for Potential Fracture
FDA (Devices) · 2020-04-01
- CriticalPipeline Flex Embolization Device Recalled for Potential Push Wire Fracture Risk
FDA (Devices) · 2021-09-15
- ModerateMicro Therapeutics Recalls Pipeline Flex Embolization Device Due to Labeling Error
FDA (Devices) · 2026-10-07
- CriticalFDA Recalls Pipeline Embolization Devices Due to Coating Delamination
FDA (Devices) · 2016-11-16